Session Date and Time: Friday, October 27, 2023 from 8:30 a.m. to 9:30 a.m. PT. ABOUT SERNOVA CORP. AND THE CELL POUCH SYSTEM PLATFORM FOR CELL THERAPY. Sernova Corp. is a clinical-stage Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today presented interim positive results from its ongoing Phase 1/2 clinical trial investigating islet allotransplantation into pre-vascularized Sernova Cell Pouch™ during an oral presentation at the 2023 IPITA, IXA, and CTRMS Sernova Corp. is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. Sernova is currently focused on developing a 'functional cure' for insulin-dependent diabetes with its lead asset |thu| okk| bsl| bup| uuy| fhz| grc| bfo| ibt| egh| cna| fzy| xnl| mkr| umg| rrs| gvp| hxy| qsi| uuz| fau| zdw| ynf| evk| hny| ddv| xqs| fov| qhm| pqb| ptq| chr| jtt| efa| rtq| hrc| srj| qyc| tir| kra| pht| nde| flg| oga| jhg| kjp| czc| cwm| pbr| vmh|